Latest filings (excl ownership)
8-K
Entry into a Material Definitive Agreement
23 Sep 24
10-Q
2024 Q2
Quarterly report
8 Aug 24
8-K
Bioatla Reports Second Quarter 2024 Financial Results
8 Aug 24
8-K
Submission of Matters to a Vote of Security Holders
13 Jun 24
8-K
Other Events
17 May 24
10-Q
2024 Q1
Quarterly report
14 May 24
8-K
Bioatla Reports First Quarter 2024 Financial Results
14 May 24
8-K
Amendments to Articles of Incorporation or Bylaws
24 Apr 24
ARS
2023 FY
Annual report to shareholders
24 Apr 24
DEFA14A
Additional proxy soliciting materials
24 Apr 24
DEF 14A
Definitive proxy
24 Apr 24
S-8
Registration of securities for employees
26 Mar 24
10-K
2023 FY
Annual report
26 Mar 24
8-K
Bioatla Reports Fourth Quarter and Full Year 2023 Financial Results
26 Mar 24
8-K
Departure of Directors or Certain Officers
21 Feb 24
8-K
Other Events
12 Feb 24
8-K
Regulation FD Disclosure
9 Jan 24
8-K
Amendments to Articles of Incorporation or Bylaws
8 Jan 24
8-K
BioAtla Hosting Virtual R&D Day to Highlight BA3071 CAB-CTLA-4 Phase 1 Data in Multiple Solid Tumor Types
13 Dec 23
8-K
Other Events
4 Dec 23
10-Q
2023 Q3
Quarterly report
7 Nov 23
8-K
Bioatla Reports Third Quarter 2023 Financial Results
7 Nov 23
10-Q
2023 Q2
Quarterly report
1 Aug 23
8-K
Bioatla Reports Second Quarter 2023 Financial Results
1 Aug 23
8-K
Submission of Matters to a Vote of Security Holders
14 Jun 23
10-Q
2023 Q1
Quarterly report
11 May 23
8-K
Bioatla Reports First Quarter 2023 Financial Results
11 May 23
DEFA14A
Additional proxy soliciting materials
24 Apr 23
ARS
2022 FY
Annual report to shareholders
24 Apr 23
DEF 14A
Definitive proxy
24 Apr 23
S-8
Registration of securities for employees
23 Mar 23
10-K
2022 FY
Annual report
23 Mar 23
8-K
Bioatla Reports Fourth Quarter and Full Year 2022 Financial Results
23 Mar 23
8-K
Regulation FD Disclosure
10 Mar 23
8-K
BioAtla Announces Change in Executive Leadership
27 Feb 23
8-K
Departure of Directors or Certain Officers
15 Feb 23
EFFECT
Notice of effectiveness
18 Jan 23
CORRESP
Correspondence with SEC
13 Jan 23
UPLOAD
Letter from SEC
13 Jan 23
S-3
Shelf registration
6 Jan 23
Latest ownership filings
SC 13D/A
Soleus Private Equity Fund I, L.P.
6 Sep 24
4
Scott Andrew Smith
3 Sep 24
4
Eric Sievers
3 Sep 24
SC 13G
MILLENNIUM MANAGEMENT LLC
7 Aug 24
4
Scott Andrew Smith
1 Aug 24
4
Eric Sievers
1 Aug 24
SC 13G/A
BlackRock Inc.
8 Jul 24
4
Scott Andrew Smith
1 Jul 24
4
Eric Sievers
1 Jul 24
4
MARY ANN GRAY
14 Jun 24
4
SYLVIA MCBRINN
14 Jun 24
4
Scott Andrew Smith
14 Jun 24
4
LAWRENCE STEINMAN
14 Jun 24
4
Eddie Williams
14 Jun 24
4
Susan Moran
14 Jun 24
4
Scott Andrew Smith
31 May 24
4
Eric Sievers
31 May 24
4
Eric Sievers
1 May 24
4
Scott Andrew Smith
1 May 24
SC 13D/A
Soleus Private Equity Fund I, L.P.
16 Apr 24
4
Scott Andrew Smith
1 Apr 24
4
Eric Sievers
1 Apr 24
4
Scott Andrew Smith
1 Mar 24
4
Eric Sievers
1 Mar 24
4
RICHARD A WALDRON
20 Feb 24
4
Christian Vasquez
20 Feb 24
4
Eric Sievers
20 Feb 24
4
JAY M PHD SHORT
20 Feb 24
SC 13G/A
TANG CAPITAL PARTNERS LP
14 Feb 24
SC 13G/A
SHORT JAY M PHD
9 Feb 24
SC 13G/A
ACORN BIOVENTURES, L.P.
6 Feb 24
4
Scott Andrew Smith
1 Feb 24
4
Eric Sievers
1 Feb 24
SC 13G
BlackRock Inc.
29 Jan 24
4
SYLVIA MCBRINN
19 Jan 24
4
Eddie Williams
3 Jan 24
4
MARY ANN GRAY
3 Jan 24
4
Scott Andrew Smith
3 Jan 24
4
Eric Sievers
3 Jan 24
4
SYLVIA MCBRINN
26 Dec 23